Top Markets
Coin of the day
Joyzyme Group Limited Joyzyme Group Limited

Joyzyme Group Limited

8622
Rang in aandelen #32061
Huakang Biomedical Holdings Company Limited operates as an investment holding... Huakang Biomedical Holdings Company Limited operates as an investment holding firm, primarily dedicated to the research, development, manufacturing, marketing, and distribution of in-vitro diagnostic (IVD) reagents within the People's Republic of China. Its comprehensive product portfolio encompasses IVD reagents designed for assessing male and female fertility, detecting parasite antibodies, and identifying the Epstein-Barr virus. Additionally, the company provides auxiliary reproductive supplies and equipment, alongside a range of healthcare products and nutritional supplements marketed under its 'Nutronic' brand, which are sold through both digital and physical platforms. Products are distributed directly to hospitals and medical institutions, as well as through a network of third-party distributors. The company was founded in 1992 and maintains its headquarters in Wan Chai, Hong Kong.
Aandeelprijs
$0.02174746
Marktkapitalisatie
$11.21M
Verandering (1 dag)
-0.58%
Verandering (1 jaar)
-55.25%
Land
HK
Handel Joyzyme Group Limited (8622)

Categorie

Winst voor Joyzyme Group Limited (8622)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van Joyzyme Group Limited bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Joyzyme Group Limited van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten